ME/NaPhos/MB/Hyo1 and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of ME/NaPhos/MB/Hyo1 and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyoscyamine / methenamine / methylene blue / sodium biphosphate
Brand name: Urogesic-Blue, UTA, Uro-BLUE, Urolet MB, Indiomin MB, ME/NaPhos/MB/Hyo1, UTA
Synonyms: Hyoscyamine, methenamine, methylene blue, and sodium biphosphate, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- ME/NaPhos/MB/Hyo1-Moxifloxacin
- ME/NaPhos/MB/Hyo1-Moxifloxacin (Systemic)
- ME/NaPhos/MB/Hyo1-Moxifloxacin Hydrochloride
- ME/NaPhos/MB/Hyo1-Moxifloxacin Injection
- ME/NaPhos/MB/Hyo1-Moxifloxacin Intravenous
- ME/NaPhos/MB/Hyo1-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Measles and rubella virus vaccine live Intramuscular, Injection
- Moxetumomab pasudotox-tdfk Intravenous-Measles virus vaccine, live Subcutaneous
- Moxetumomab pasudotox-tdfk Intravenous-Measles, mumps, and rubella (MMR) vaccine
- Moxetumomab pasudotox-tdfk Intravenous-Measles, Mumps, and Rubella Vaccine
- Moxetumomab pasudotox-tdfk Intravenous-Measles, Mumps, and Rubella Virus Vaccine
- Moxetumomab pasudotox-tdfk Intravenous-Measles, mumps, and rubella virus vaccine live Subcutaneous, Intramuscular